Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AF Ablation: Progress & Promise

Executive Summary

Tremendous progress has been made in the field of ablation therapy for atrial fibrillation (AF) over the past several years, and numerous device-based technologies to address this underserved and rapidly growing patient population are under clinical development. Minimally invasive, percutaneous AF ablation has evolved rapidly as well, although the procedure remains very challenging and limited to highly experienced centers.

Related Content

Endosense: Facing Technology and Financing Challenges in AF
Medtech Investing 2009: What's Changed?
Medtronic Strengthens Hand in Ablation Market with CryoCath Acquisition
Sensing the State of the CRM Market
EuroPACE Highlights: AF Cath Ablation Interest Heats Up
Tapping the Potential of Atrial Fibrillation Devices
Endosense: Growing Up Fast in AF
St. Jude Medical: Dealing Its Way to the Top in AF
Atritech Inc.
AtriCure: Making Order Out Of Chaos


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts